Precision OS Trains More Than 300 Medical Device Representatives in 30 Minutes Using Virtual Reality

Precision OS Technology, developers of the medical-grade learning platform that advances surgical readiness, announced today that it carried out the first-ever and largest virtual reality training event of its kind for medical device representatives.

Held Jan. 22-25, the event brought together more than 300 medical device representatives who simultaneously accessed the training module on a complex surgical procedure. Precision OS was pleased to collaborate on the event with one of its most trusted partners in the medical device industry.

“Our educational approach has always been to deliver content that includes and goes beyond the implant,” said Dr. Danny Goel, a practicing orthopedic surgeon and Chief Executive Officer, Precision OS. “When considering how best to influence care and the transfer of appropriate knowledge to care providers, we must think along different models of education. Given these representatives provide an important role in the operating room, equipping them with advanced skills, implant comprehension and support capabilities efficiently and effectively is critical during multistep implantation of devices.”

The Precision OS training uses the mobile Oculus Quest and can be completed anywhere at anytime. Participants on the Precision OS platform can complete this multistep procedure in less than 30 minutes.

The virtual reality educational modules built by Precision OS provide a much-needed alternative to the time-intensive and costly exercises associated with traditional sales training. These reps have also historically resorted to flying to cadaver labs, listening to lectures, utilizing non-interactive training sessions via tablet and learning on-the-job during actual cases.

Despite the consistent use of these methods, studies have proven them to be less effective in the area of knowledge retention and skill transfer. Further, on-the-job learning presents significant risk variables which can influence patient outcomes and delay adequate support for complex procedures.

The Precision OS technology puts patient safety and outcomes back into the center of training, which both medical device reps and surgeons desire and appreciate.

After comparing and analyzing its method of training with those that have been traditionally used, Precision OS found a 570% gain in efficiency in learning with its approach in senior orthopedic surgical residents.

This landmark study, scheduled for publication in the coveted Journal of Bone and Joint Surgery (American) in the coming weeks, met the prestigious journal’s rigorous peer-reviewed standards for research. A major strength of the study was the research collaboration with the Canadian Shoulder and Elbow Society (CSES).

Virtual reality imparts an unmatched level of contextual learning by improving understanding, technical skills and surgical readiness. The Precision OS modules supply its users with deliberate practice that is cost-effective and scalable on a global level

“Considering the high stakes, effectively educating all members of the patient care pathway ensures we have the greatest chance to positively impact outcomes,” said Dr. Goel. “Our primary tenet is to be patient-centered and provider-focused. This is part of our culture and vision to deliver advanced education around the world.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version